China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
0.9200
-0.0150 (-1.60%)
Last updated: May 13, 2025
3.37%
Market Cap 2.30B
Revenue (ttm) 988.38M
Net Income (ttm) 214.35M
Shares Out n/a
EPS (ttm) 0.09
PE Ratio 10.72
Forward PE 11.26
Dividend 0.03 (3.56%)
Ex-Dividend Date Apr 28, 2025
Volume n/a
Average Volume 120
Open 0.9250
Previous Close 0.9350
Day's Range 0.9200 - 0.9250
52-Week Range 0.7100 - 1.1700
Beta n/a
RSI 52.04
Earnings Date May 15, 2025

About FRA:2M7C

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 6,141
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.